Editas Medicine, Inc.
EDITNASDAQHealthcare● Active
$2.65
$-0.07(-2.40%)
Market Cap$258946127
P/E Ratio—
52W High$4.537
52W Low$1.66
Editas Medicine, Inc. (EDIT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EDIT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $40.52M | $32.31M | $78.12M | $19.71M | $25.54M |
| Cost of Revenue | $0.00M | $0.00M | $6.06M | $6.34M | $5.05M |
| Gross Profit | $40.52M | $32.31M | $72.06M | $13.38M | $20.49M |
| Gross Margin %(computed) | 100.00% | 100.00% | 92.24% | 67.85% | 80.22% |
| Operating Expenses | |||||
| R&D Expenses | $89.95M | $199.25M | $177.65M | $174.96M | $142.51M |
| G&A Expenses | $49.90M | $71.99M | $69.65M | $70.70M | $76.18M |
| Total Operating Expenses | $139.86M | $283.47M | $241.24M | $239.32M | $213.64M |
| Operating Income | ($99.34M) | ($251.15M) | ($169.18M) | ($225.95M) | ($193.15M) |
| Operating Margin %(computed) | -245.15% | -777.22% | -216.56% | — | -756.13% |
| Interest Income | $8.31M | $14.06M | $17.57M | $5.52M | $0.61M |
| Interest Expense | $6.17M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($160.06M) | ($237.09M) | ($153.22M) | ($220.43M) | ($192.50M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($160.06M) | ($237.09M) | ($153.22M) | ($220.43M) | ($192.50M) |
| Net Margin %(computed) | -395.01% | -733.72% | -196.13% | — | -753.61% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.80 | $-2.88 | $-2.02 | $-3.21 | $-2.85 |
| Wtd Avg Shares | 88.75M | 82.34M | 75.97M | 68.66M | 67.62M |
| EBITDA | ($148.61M) | ($233.11M) | ($163.12M) | ($219.61M) | ($188.09M) |
| EBITDA Margin %(computed) | -366.76% | -721.39% | -208.80% | — | -736.35% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Editas Medicine, Inc. data
About Editas Medicine, Inc. (EDIT) Income Statement
Editas Medicine, Inc. (EDIT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EDIT reported revenue of $0.04B, gross profit of $0.04B (gross margin 100.00%), and net income of ($0.16B) — a net profit margin of -395.01%.
Frequently asked questions
EDIT · 4 questionsEditas Medicine, Inc. (EDIT) reported revenue of $0.04B for 2025, up 25.4% year-over-year.
EDIT revenueEDIT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08